Study at a glance
Where does vitamin D go and get stored in the human body?
This study examined where vitamin D goes and is stored in human tissues, including samples collected after death. Researchers injected vitamin D3 marked with a radioactive label so they could track it. They also tested tissue extracts for vitamin D activity related to preventing rickets, a bone disease. The label showed where vitamin D-related substances went; the biological tests checked whether some remained active.
Where was vitamin D found?
Injected vitamin D3 left the blood quickly, and labelled substances were found throughout the tissues examined. Fat tissue had the highest concentrations of both the label and biological activity. This supported fat as a main storage site. Muscle also contributed because the body contains a large amount of it. Vitamin D activity remained in these tissues over time.
How were substances made from vitamin D released into bile?
Substances formed from vitamin D were released into bile, a fluid produced by the liver. Most had been chemically changed, although smaller amounts of unchanged vitamin D3 and another vitamin D form were also present. Some explanations for tissue uptake and liver removal were suggested rather than directly demonstrated.
Does this study show how much vitamin D the body can store?
Newly labelled vitamin D mixed with existing stores, making the results harder to interpret. The study did not establish exactly how much could be stored, how long it remained or how quickly it returned to blood. It did not establish health benefits, supplement doses or personal targets. A blood result alone cannot measure all vitamin D stored in tissues.
Read the full article below ↓This page presents a full-length, evidence-disciplined analysis of the primary scientific paper entitled “The distribution and storage of vitamin D and its metabolites in man,” authored by Mawer EB, Stanbury SW, and colleagues, and published in Clinical Science in 1972. The purpose of this page is to function as the definitive, canonical Full Study record for this paper within the VitaminD3ForLife framework. It is intentionally long, slow, and exhaustive in its treatment of the study, reflecting both the historical importance of the work and the continuing relevance of its findings to modern vitamin D physiology. See also, Summary of this study page.
Unlike summary-level treatments, this page does not seek brevity, accessibility, or simplification. Instead, it seeks fidelity to what was actually done, measured, observed, and cautiously inferred by the original investigators. Where the study reports observations, those observations are described in detail. Where the study refrains from making claims, this restraint is preserved. Where the study introduces uncertainty, methodological limitation, or tentative inference, those boundaries are explicitly stated and respected.
The analysis remains strictly confined to the content of the original paper and clearly identified interpretive commentary derived from it. No external studies are introduced. No clinical recommendations are made. No modern mechanistic frameworks are retrofitted onto the data. The study is allowed to remain a product of its time, examined carefully rather than rewritten to fit contemporary narratives.
Historical and scientific context of the study
When this study was conducted and published in the early 1970s, the scientific understanding of vitamin D was in a markedly different state than it is today. Vitamin D was already recognised as essential for bone health and the prevention of rickets, and its antiricketic activity had been studied for decades. However, much of this understanding was functionally oriented rather than systemically grounded. Vitamin D was often conceptualised as something that entered the body, circulated, and exerted effects, without a clear empirical map of where it resided once absorbed or synthesised.
At that time, circulating measurements were the dominant, and often the only, practical means of assessing vitamin D status. Blood was accessible, sampling was feasible, and assays could be standardised. By contrast, direct examination of tissues in humans was rare, ethically complex, and technically demanding. As a result, assumptions about whole-body vitamin D availability were often extrapolated from serum values without direct confirmation.
The Mawer et al. study emerged in this context as an attempt to address a fundamental and largely unanswered question: what actually happens to vitamin D once it enters the human body? Does it remain primarily in circulation? Is it rapidly metabolised and eliminated? Or does it accumulate in tissues, forming reservoirs that alter the relationship between intake, blood levels, and biological availability?
The historical significance of the study is amplified by the fact that it made use of human autopsy tissue. Such access enabled direct measurement of vitamin D and its metabolites within multiple tissue compartments. Today, this kind of study would be extremely difficult to replicate, not because the question is unimportant, but because the methodological conditions that allowed it no longer exist at scale.
The central physiological question addressed
The core physiological question at the heart of the study concerns the fate of vitamin D in the human body after entry into the circulation. Specifically, the investigators sought to determine how vitamin D and its metabolites are distributed across tissues, whether certain tissues act as storage sites, and how long vitamin D-derived compounds persist within these compartments.
This question is deceptively simple but has profound implications. If vitamin D is stored extensively in tissues, then circulating levels may represent only a transient or partial snapshot of total body vitamin D. Conversely, if vitamin D is not stored and is rapidly cleared, then serum concentrations might closely track recent intake or synthesis.
The study does not approach this question with the aim of redefining deficiency or sufficiency thresholds. Instead, it addresses a more foundational layer of physiology: compartmental distribution. It asks where vitamin D resides, not what it does clinically.
Overview of the experimental strategy
To investigate vitamin D distribution, the study employed a combined experimental strategy that integrated radioactive tracing with biological assays of antiricketic activity. Each component of this strategy addressed a different evidentiary need, and neither would have been sufficient on its own.
Radioactive cholecalciferol was used to trace the physical movement of vitamin D through the body following injection. This allowed the investigators to follow the distribution of labelled vitamin D-derived compounds across tissues over time. However, radioactivity alone cannot distinguish between biologically active vitamin D, inactive metabolites, or degradation products.
To address this limitation, biological assays of antiricketic activity were performed on tissue extracts. These assays provided functional evidence that the compounds present retained biological activity relevant to vitamin D’s known physiological role. The combination of radioactive tracing and biological activity measurement thus allowed the investigators to assess both presence and functional relevance.
Clearance of radioactive cholecalciferol from the blood
One of the earliest observations reported in the study is the rapid clearance of injected radioactive cholecalciferol from the bloodstream. Following administration, radioactivity associated with cholecalciferol declined quickly in circulating blood samples.
This rapid clearance indicates that blood does not serve as a long-term reservoir for vitamin D. Instead, the circulation functions primarily as a transport pathway, delivering vitamin D to other compartments. The study does not attempt to model clearance kinetics quantitatively, but the qualitative observation is clear and consistent.
This finding alone challenges any assumption that circulating vitamin D levels reflect a stable pool. Rather, it suggests that blood concentrations are transient and dependent on ongoing exchange with tissues.
Distribution of vitamin D and metabolites across tissues
Following clearance from the blood, radioactive vitamin D and its metabolites were detected in all tissues examined. This finding establishes that vitamin D distribution is systemic rather than restricted to a small number of organs.
The study reports detection of both unchanged cholecalciferol and various metabolites in tissue samples. This indicates that tissues are exposed to multiple chemical forms of vitamin D, not solely the parent compound.
Importantly, tissue detection was not based solely on radioactivity. Biological assays demonstrated antiricketic activity within tissue extracts, confirming that at least some of the retained compounds were biologically active.
Adipose tissue as the principal storage site
Among all tissues examined, adipose tissue exhibited the highest concentration of both radioactivity and biological activity. This dual finding led the investigators to conclude that adipose tissue is the principal site of vitamin D storage in humans.
The study further demonstrated that vitamin D activity persisted in adipose tissue over a prolonged period. This persistence distinguishes storage from transient distribution and supports the interpretation of fat as a long-term reservoir.
The investigators did not attempt to quantify absolute storage capacity or release rates. However, the qualitative evidence of persistence is robust within the limits of the study design.
Skeletal muscle as a secondary storage compartment
Voluntary, or skeletal, muscle was identified as another significant site of vitamin D storage. Although concentrations per unit mass were lower than those observed in adipose tissue, the large total mass of skeletal muscle means that it contributes meaningfully to overall body storage.
This finding broadens the concept of vitamin D storage beyond fat alone. It suggests that storage is distributed across multiple tissue types rather than confined to a single specialised compartment.
Persistence and temporal considerations
The study demonstrates that vitamin D-derived activity can persist in tissues for extended periods. However, it does not define the precise duration of retention, nor does it establish rates of release back into circulation.
Temporal dynamics are therefore implied rather than quantified. The study shows that storage exists, but it does not resolve how storage interacts with changing intake, synthesis, or physiological demand.
Pre-existing tissue pools and methodological constraints
A critical methodological insight highlighted by the authors is the influence of pre-existing tissue pools of vitamin D. When tissues already contain vitamin D, newly administered radioactive cholecalciferol may mix with these pools, complicating interpretation of tracer data.
This observation underscores a fundamental limitation of radioactive tracing in biological systems that are not naïve to the compound being studied. The study explicitly cautions that tracer-based distribution patterns may be distorted by existing stores.
Uptake of 25-hydroxycholecalciferol into tissues
In addition to parent cholecalciferol, the study examined the distribution of metabolically produced 25-hydroxycholecalciferol. This metabolite was observed to be taken up from the blood into many tissues.
The uptake of 25-hydroxycholecalciferol is described as probably mediated by protein binding. This mechanism is inferred based on observed behaviour rather than directly demonstrated.
Biliary excretion of vitamin D and metabolites
The study reports that vitamin D is excreted in bile primarily as more polar metabolites. This finding identifies biliary excretion as a major elimination pathway following metabolic modification.
Smaller quantities of unchanged cholecalciferol and 25-hydroxycholecalciferol were also detected in bile. Notably, antiricketic activity was demonstrated in bile samples, confirming the presence of biologically active compounds.
Physicochemical processes governing excess elimination
When excess cholecalciferol or 25-hydroxycholecalciferol is present in the blood, the study suggests that elimination occurs via physicochemical processes. These include partitioning into tissue lipid and binding to tissue proteins.
These processes are described as passive rather than regulated. They are presented as consequences of molecular properties rather than adaptive physiological controls.
Tentative inferences and explicit boundaries
The authors tentatively infer that increased concentrations of vitamin D or its metabolites in the liver may lead to increased biliary excretion and increased formation of polar metabolites. These statements are explicitly identified as inferences rather than measured outcomes.
The study maintains a clear boundary between observation and speculation, a feature that contributes to its enduring credibility.
Enduring relevance and interpretive importance
The Mawer et al. study continues to be cited more than half a century after publication because it addresses a question that remains incompletely resolved. Modern vitamin D research still grapples with the relationship between circulating measurements and total body status.
The study’s demonstration of extensive tissue storage challenges simplistic interpretations of serum values and underscores the need for caution when drawing conclusions from blood measurements alone.
What the study establishes
This study establishes that vitamin D and its metabolites are widely distributed in human tissues, that adipose tissue and skeletal muscle act as principal storage sites, that biologically active compounds persist in these tissues, and that elimination occurs primarily via biliary excretion of polar metabolites.
What the study does not establish
The study does not establish optimal intake levels, clinical outcomes, mobilisation kinetics, or regulatory feedback mechanisms. It does not define deficiency or sufficiency, and it does not provide guidance for supplementation or treatment.
Placement within vitamin D physiology
Within the broader physiological framework, this study supports a distributed, multi-compartment model of vitamin D handling. It informs interpretation of systemic availability described in Vitamin D in the Body, storage discussed in Vitamin D Storage, and downstream action outlined in Where Vitamin D Acts.
Extended analytical commentary on the Mawer et al. study
The paper by Mawer, Stanbury, and colleagues occupies a unique position in the vitamin D literature, not because it answers every question about vitamin D physiology, but because it addresses one of the most fundamental questions that underpins all later interpretation: what actually happens to vitamin D once it enters the human body. This question is deceptively simple. It is easy to assume that vitamin D status can be inferred directly from blood measurements, or that vitamin D behaves like a short-lived circulating hormone whose effects are tightly coupled to serum concentration. The Mawer et al. study forces a reconsideration of those assumptions by demonstrating, through direct human tissue analysis, that vitamin D is a distributed, stored, and slowly turning-over substance rather than a purely transient signal.
Why this study represented a methodological advance
At the time of publication in 1972, the methodological approach used in this study was unusually ambitious. The combined use of radioactive cholecalciferol tracing and biological assays of antiricketic activity allowed the investigators to examine vitamin D physiology at multiple evidentiary levels simultaneously. Radioactive tracing alone would have established distribution but not biological relevance. Biological assays alone would have demonstrated activity but not spatial origin. The integration of these approaches enabled a more complete, albeit still imperfect, picture of vitamin D handling in the human body.
Crucially, the study relied on access to human autopsy tissue. This fact alone distinguishes it from the majority of vitamin D research conducted before and since. Animal models can approximate aspects of vitamin D metabolism, but they cannot fully replicate human tissue distribution patterns, particularly in relation to adipose tissue and skeletal muscle mass. Ethical, regulatory, and practical constraints now make such studies exceedingly rare, which confers a lasting evidentiary value on this work that is independent of its age.
The importance of studying distribution rather than outcomes
One of the most striking features of the Mawer et al. paper is what it does not attempt to do. The study does not seek to link vitamin D distribution to clinical outcomes, disease states, or therapeutic thresholds. It does not propose optimal intake levels or interpret its findings in terms of health benefits or risks. Instead, it remains focused on a prior layer of understanding: physical distribution, storage, persistence, and elimination.
This restraint is not a limitation but a strength. By avoiding outcome-driven interpretation, the study provides foundational data that can be used to interrogate later assumptions. Many controversies in modern vitamin D research arise precisely because outcome studies are interpreted without sufficient grounding in distributional physiology. The Mawer et al. study reminds the reader that without knowing where vitamin D resides, it is difficult to interpret what circulating measurements actually represent.
Tissue storage as a challenge to serum-centric models
Perhaps the most enduring contribution of the study is its clear demonstration that vitamin D is stored extensively in human tissues, particularly adipose tissue and skeletal muscle. This finding directly challenges any model that treats serum vitamin D concentration as a near-complete representation of total body vitamin D. Instead, serum emerges as a dynamic interface between intake, storage, metabolism, and elimination.
The identification of adipose tissue as the principal storage site is especially important. Adipose tissue is not metabolically inert, nor is it a trivial compartment in humans. Its capacity to retain vitamin D-derived compounds over prolonged periods introduces temporal buffering into the system. Changes in intake or synthesis may not be reflected immediately in circulating levels, and conversely, circulating levels may decline while substantial tissue stores remain.
The additional identification of skeletal muscle as a secondary storage site further complicates simplistic models. Skeletal muscle represents a large proportion of total body mass, and even modest concentrations of stored vitamin D can contribute significantly to total body content. This distributed storage model implies that vitamin D availability is influenced not only by intake and metabolism but also by body composition.
Persistence, buffering, and temporal disconnects
The study’s demonstration of prolonged retention of vitamin D activity in tissues introduces an important temporal dimension to vitamin D physiology. Vitamin D does not behave like a rapidly cleared signal whose biological effects track closely with moment-to-moment changes in serum concentration. Instead, it behaves more like a stored resource, with slow accumulation and slow depletion.
This temporal buffering has profound implications for interpretation. Short-term changes in serum vitamin D may reflect redistribution rather than true deficiency or excess. Conversely, stable serum levels may mask gradual depletion or accumulation within tissues. The Mawer et al. study does not quantify these dynamics, but it establishes their existence, which is a necessary first step.
Pre-existing tissue pools and the limits of tracer studies
One of the most methodologically insightful aspects of the paper is its explicit discussion of pre-existing tissue pools of vitamin D. The authors recognise that when tissues already contain vitamin D, the introduction of radioactively labelled cholecalciferol does not occur into an empty system. Instead, the tracer mixes with existing pools, complicating interpretation of distribution patterns.
This observation highlights a broader issue in physiological tracing studies: labelled compounds do not necessarily behave identically to unlabelled endogenous compounds when pre-existing stores are present. The Mawer et al. study is unusually explicit in acknowledging this limitation, thereby preventing overinterpretation of its own tracer data.
Multiple chemical forms and tissue uptake
The study’s examination of both parent cholecalciferol and 25-hydroxycholecalciferol underscores that vitamin D distribution is not limited to a single chemical entity. Tissues are exposed to, and capable of retaining, multiple forms of vitamin D-derived compounds. This finding complicates any attempt to reduce vitamin D physiology to a single circulating marker.
The observation that 25-hydroxycholecalciferol is taken up into tissues, probably via protein binding, further reinforces the idea that tissue exposure is mediated by transport and binding processes rather than passive diffusion alone. Although the mechanism is inferred rather than demonstrated, the cautious framing preserves interpretive integrity.
Biliary excretion and elimination pathways
Another important contribution of the study is its identification of biliary excretion as a major elimination pathway for vitamin D-derived compounds. The demonstration that vitamin D is excreted primarily as more polar metabolites, but that smaller amounts of biologically active compounds also appear in bile, expands understanding of how excess vitamin D is handled.
This finding situates elimination within a broader system of distribution and storage. Vitamin D is not simply cleared via the kidneys in unchanged form. Instead, it undergoes metabolic transformation and is eliminated through complex pathways that include hepatic processing and biliary secretion.
Physicochemical processes rather than tight regulation
The Mawer et al. study repeatedly emphasises physicochemical processes such as lipid partitioning and protein binding as central determinants of vitamin D distribution and elimination. These processes are described as passive consequences of molecular properties rather than as tightly regulated physiological controls.
This framing is important because it tempers expectations of precise homeostatic regulation. Vitamin D handling appears to involve a combination of metabolic control and physical chemistry, which introduces variability and context-dependence into the system. This perspective remains relevant when interpreting modern data.
Why the study still matters today
Half a century after its publication, the Mawer et al. study continues to be cited not because it provides final answers, but because it provides structural insight. Modern vitamin D research still struggles with questions about variability, measurement, and interpretation. Many debates about deficiency, sufficiency, and optimal levels implicitly assume models of distribution that this study calls into question.
By demonstrating that vitamin D is widely distributed, extensively stored, and slowly eliminated, the study provides a necessary corrective to overly simplistic interpretations. It does not negate the value of serum measurements, but it clearly limits what they can represent.
What this study ultimately contributes
WThe enduring contribution of the Mawer et al. paper is not a set of numbers, thresholds, or recommendations. It is a shift in perspective. Vitamin D emerges not as a fleeting signal but as a systemically distributed substance with memory, inertia, and context-dependence. Any serious attempt to understand vitamin D physiology must begin with this recognition.
Study reference
Mawer EB, Backhouse J, Holman CAJ, Lumb GA, Stanbury SW.
The distribution and storage of vitamin D and its metabolites in man.
Clinical Science. 1972.
View study on PubMed
Related reading
Distribution and storage of vitamin D and its metabolites in man: Study Summary
Distribution and Storage of Vitamin D and Its Metabolites in Man: Study Summary.
Read more →Cost-Effectiveness of Vitamin D Supplementation in Pregnant Woman and Young Children in Preventing Rickets: A Modeling Study
Literature on the cost of management of rickets and cost-effectiveness of vitamin D supplementation in preventing rickets is lacking.
Original paper ↗Read more →Vitamin D Storage, Release and Tissue Buffering: Full Evidence Review
A critical review of human fat-tissue studies and mouse muscle research on vitamin D storage, release and buffering, with methods and limits.
Read more →Vitamin D Storage, Release and Tissue Buffering: Study Summary
A plain-English summary of what studies show about vitamin D in fat and muscle, later release, and the limits of estimating personal stores.
Read more →Vitamin D Storage
Explains how vitamin D is stored in the body, how storage buffers availability over time, and why stored vitamin D complicates interpretation of blood levels and status.
Read more →Association of longitudinal serum 25-hydroxyvitamin D trajectories with subsequent liver stiffness increase in patients with early-onset type 2 diabetes and metabolic dysfunction-associated steatotic liver disease
We evaluated the associations of longitudinal 25(OH)D trajectories with subsequent liver stiffness measurement (LSM) increases in patients with early-onset type 2 diabetes and metabolic dysfunction-associated steatotic liver disease.
Original paper ↗Read more →Bone Turnover Markers and Bone Mineral Density in Children with Hypophosphatemic Rickets
Hypophosphatemic rickets is a rare disease that results in bone deformities.
Original paper ↗Read more →Coactivator-independent vitamin D receptor signaling causes severe rickets in mice, that is not prevented by a diet high in calcium, phosphate, and lactose
The vitamin D receptor (VDR) plays a critical role in the regulation of mineral and bone homeostasis.
Original paper ↗Read more →Comprehensive evaluation of the efficacy and safety of different vitamin D combination regimens based on indirect comparisons for children with rickets: a network meta-analysis
Ten randomized controlled trials involving 867 children were included, comparing nine vitamin D: based combination regimens with vitamin D3 monotherapy.
Original paper ↗Read more →Incidence of malnutrition and changes in phosphocalcic metabolism in perioperative liver transplantation patients: a retrospective study in a tertiary children’s hospital in China
The primary aim of the study was to assess the nutritional status of pediatric liver transplant outpatients in nutrition clinic, particularly the nutritional status of their bones.
Original paper ↗Read more →Intact FGF23 concentration in healthy infants, children, and adolescents, and diagnostic usefulness in patients with X-linked hypophosphatemic rickets
FGF23 measurement may have a diagnostic role to investigate patients with phosphate disorders.
Original paper ↗Read more →Metabolic Phenotyping of Nutritional Rickets in Bangladeshi Children
Nutritional rickets is a childhood bone disorder leading to skeletal deformities and life-long disabilities.
Original paper ↗Read more →Relationship between non-alcoholic fatty liver and progressive fibrosis and serum 25-hydroxy vitamin D in patients with type 2 diabetes mellitus
We aimed to analyze the relationship between non-alcoholic fatty liver and progressive fibrosis and serum 25-hydroxy vitamin D (25(OH)D) in patients with type 2 diabetes mellitus.
Original paper ↗Read more →Relationship of Vitamin D Deficiency and Fatty Liver in Children as Defined by Multiple Imaging and Histologic Endpoints
All participants had liver imaging, namely, controlled attenuation parameter to assess steatosis and, to assess fibrosis, vibration controlled transient elastography (FibroScan), and acoustic radiation force impulse imaging.
Original paper ↗Read more →Temporal trend of serum vitamin profiles and the association with non-alcoholic fatty liver disease
This study aimed to characterize temporal trends of serum vitamins (A, B9, B12, D, E) among Chinese adults undergoing health examinations (2015 to 2023) and explore their associations with NAFLD.
Original paper ↗Read more →The Role of Vitamin D and Vitamin D Binding Protein in Chronic Liver Diseases
Vitamin D (calciferol) is a fat-soluble vitamin that has a significant role in phospho-calcium metabolism, maintaining normal calcium levels and bone health development.
Original paper ↗Read more →The Variant p.Ala84Pro Is Causative of X-Linked Hypophosphatemic Rickets: Possible Relationship with Burosumab Swinging Response in Adults
Loss of function mutations in the PHEX gene could determine X-linked dominant hypophosphatemia.
Original paper ↗Read more →Vitamin D receptor ApaI polymorphism associated with progression of liver disease in Vietnamese patients chronically infected with hepatitis B virus
In the recessive model, the genotype ApaI AA was found more frequently among HCC compared to CHB patients (OR = 2.56, 95%CI = 1.01 to 6.48, P = 0.04).
Original paper ↗Read more →Vitamin D Receptor Polymorphism among Rickets Children in Mongolia
We therefore investigated whether VDR polymorphism is related to high prevalence of rickets in Mongolia and to bone properties in childhood.
Original paper ↗Read more →Vitamin D Supplementation and Non-Alcoholic Fatty Liver Disease: Present and Future
The aim of this review is to give an overview of the evidence currently available from clinical trials and to discuss possible shortcomings and new strategies to be considered in future investigations.
Original paper ↗Read more →Liver Disease, Carrier Proteins and Vitamin D Availability: Full Study
How liver disease changes vitamin D interpretation: biopsy findings, carrier proteins, free and total measurements, and limits of treatment claims.
Read more →Original sources
View study on PubMed
View study on PubMed.
Publication details
View study on PubMed